Post-PCI Antiplatelet Therapy — MRCP Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

MediumCardiologyPost-PCI Antiplatelet Therapymrcp part 1

A 54-year-old underwent drug-eluting stent placement for NSTEMI without high bleeding risk. What is the recommended antiplatelet strategy?

Educational content. Not a substitute for clinical judgement or local policy.

Post-PCI Antiplatelet Therapy — MRCP Part 1 MCQ | iatroX